Abbott (ABT) Tops Q1 EPS by 4c, Offers Guidance

Go back to Abbott (ABT) Tops Q1 EPS by 4c, Offers Guidance

Abbott Reports First-Quarter 2023 Results; Increases Outlook For Underlying Base Business

April 19, 2023 7:15 AM EDT

Sales of $9.7 billion driven by strong underlying base business performance Reported sales decreased 18.1 percent due to anticipated decline in COVID-19 testing-related sales versus prior yearOrganic sales growth for underlying base business of 10.0 percent, led by Medical Devices, Established Pharmaceuticals and Nutrition

ABBOTT PARK, Ill., April 19, 2023 /PRNewswire/ -- Abbott (NYSE: ABT) today announced financial results for the first quarter ended March 31, 2023.

First-quarter... More